PRTA
Prothena Corporation PLC
Price:  
20.41 
USD
Volume:  
560,036.00
Ireland | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PRTA EV/EBITDA

-195.6%
Upside

As of 2024-06-16, the EV/EBITDA ratio of Prothena Corporation PLC (PRTA) is -2.56. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PRTA's latest enterprise value is 550.93 mil USD. PRTA's TTM EBITDA according to its financial statements is -215.58 mil USD. Dividing these 2 quantities gives us the above PRTA EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 5.6x - 11.2x 7.0x
Forward P/E multiples 6.2x - 13.4x 7.8x
Fair Price (14.85) - (34.66) (19.51)
Upside -172.8% - -269.8% -195.6%
20.41 USD
Stock Price
(19.51) USD
Fair Price

PRTA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-06-14 -2.56
2024-06-13 -2.80
2024-06-12 -2.82
2024-06-11 -2.58
2024-06-10 -2.71
2024-06-07 -2.74
2024-06-06 -2.87
2024-06-05 -3.06
2024-06-04 -2.98
2024-06-03 -2.99
2024-05-31 -2.66
2024-05-30 -2.51
2024-05-29 -2.37
2024-05-28 -2.44
2024-05-24 -2.46
2024-05-23 -2.48
2024-05-22 -2.85
2024-05-21 -2.86
2024-05-20 -3.11
2024-05-17 -3.08
2024-05-16 -3.30
2024-05-15 -3.05
2024-05-14 -2.62
2024-05-13 -2.63
2024-05-10 -2.79
2024-05-09 -2.95
2024-05-08 -3.21
2024-05-07 -3.34
2024-05-06 -3.39
2024-05-03 -3.18
2024-05-02 -2.96
2024-05-01 -2.81
2024-04-30 -2.54
2024-04-29 -2.75
2024-04-26 -2.67
2024-04-25 -2.59
2024-04-24 -2.59
2024-04-23 -2.59
2024-04-22 -2.78
2024-04-19 -2.74
2024-04-18 -2.60
2024-04-17 -2.70
2024-04-16 -2.79
2024-04-15 -2.95
2024-04-12 -3.01
2024-04-11 -3.27
2024-04-10 -3.16
2024-04-09 -3.34
2024-04-08 -3.37
2024-04-05 -3.29